Cargando…

Immunoadsorption in dilated cardiomyopathy

Detalles Bibliográficos
Autores principales:	Wakabayashi, Y, Baba, A, Akaishi, M, Yoshikawa, T, Monkawa, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084165/ http://dx.doi.org/10.1186/cc7443

Ejemplares similares

Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column—A prospective, multicenter, randomized, within‐patient and parallel‐group comparative study to evaluate efficacy and safety
por: Yoshikawa, Tsutomu, et al.
Publicado: (2016)

Immunoadsorption Therapy for Patients with Dilated Cardiomyopathy and Heart Failure
por: Ikeda, Uichi, et al.
Publicado: (2008)

Immunoadsorption treatment for dilated cardiomyopathy: A PRISMA-compliant systematic review and meta-analysis
por: Bian, Ru-tao, et al.
Publicado: (2021)

Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated Cardiomyopathy
por: Weinmann, Karolina, et al.
Publicado: (2019)

Immunoadsorption therapy in refractory heart failure patients with dilated cardiomyopathy: a potential therapeutic option*
por: Cavusoglu, Yuksel, et al.
Publicado: (2023)

Immunoadsorption of lipopolysaccharides, IL-6 and complement-activation product 5a in severe sepsis and septic shock
por: Schefold, J, et al.
Publicado: (2006)

Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy
por: Ameling, Sabine, et al.
Publicado: (2013)

Mechanical effects of midwall fibrosis in non-ischemic dilated cardiomyopathy
por: Taylor, Robin J, et al.
Publicado: (2014)

Left ventricular hemodynamic forces are altered in patients with dilated cardiomyopathy
por: Eriksson, Jonatan, et al.
Publicado: (2015)

Evaluation of CMR predictors of right ventricular remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Regional diffuse fibrosis and strain characteristics differ between children with hypertrophic and dilated cardiomyopathy
por: Patel, Jyoti K, et al.
Publicado: (2015)

Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution
por: Ameling, Sabine, et al.
Publicado: (2016)

Left atrial volume is associated with mid-wall fibrosis in Dilated Cardiomyopathy
por: Fanaie, Fariba, et al.
Publicado: (2011)

Potential value of T1 mapping in dilated cardiomyopathy and correlation with circumferential strain
por: Jacquier, Alexis, et al.
Publicado: (2013)

Potential value of T1 mapping in cardiac MR assessment of hypertrophic cardiomyopathy and dilated cardiomyopathy patients: preliminary results
por: Jacquier, Alexis, et al.
Publicado: (2012)

Right ventricular function in dilated cardiomyopathy: relation to location of focal myocardial fibrosis
por: Abdelrazek, Mohamed A, et al.
Publicado: (2013)

Myocardial fibrosis is not associated with reduced quality of life in patients with dilated or hypertrophic cardiomyopathy
por: Khan, Razi, et al.
Publicado: (2011)

Erratum to: Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution
por: Ameling, Sabine, et al.
Publicado: (2017)

Diffuse fibrosis in dilated cardiomyopathy results in a shorter myocardial null time
por: Han, Yuchi, et al.
Publicado: (2009)

Parameters of Right Ventricle as etiological distinction between ischemic and non-ischemic dilated cardiomyopathy
por: Gomes, Hélder Andrade, et al.
Publicado: (2015)

Association of LA volumes and mid-wall myocardial fibrosis in the Dilated cardiomyopathy patients
por: Fanaie, Fariba, et al.
Publicado: (2011)

Characterization of dilated cardiomyopathy using tissue phase mapping and extracellular volume measurement
por: Sommerville, Lewis C, et al.
Publicado: (2013)

7T versus 3T phosphorous magnetic resonance spectroscopy in patients with dilated cardiomyopathy
por: Stoll, Victoria, et al.
Publicado: (2015)

Changes in levels of BNP, CRP and leukocyte formula during exercise testing in patients with dilated cardiomyopathy
por: Peric, V, et al.
Publicado: (2013)

Comparison of myocardial mechanical properties in patients with dilated cardiomyopathy with and without acute heart failure
por: Choudhary, Naila, et al.
Publicado: (2014)

Impact of left ventricular late enhancement on pulmonary arterial hypertension in idiopathic dilated cardiomyopathy
por: Pérez-David, Esther, et al.
Publicado: (2015)

Myocardial fibrosis is a predictor of atrial fibrillation in dilated cardiomyopathy. Role of cardiovascular magnetic resonance
por: Almeida, Ana G, et al.
Publicado: (2011)

Exercise training improves cardiac function, quality of life and exercise capacity in patients with dilated cardiomyopathy
por: Holloway, Cameron J, et al.
Publicado: (2011)

The decisive role of cardiovascular MRI delayed hyperenhancement (DHE) pattern for risk stratification for dilated cardiomyopathy
por: Venero, Jose V, et al.
Publicado: (2009)

Utility of Native T1 mapping to differentiate between athlete's heart and non-ischemic dilated cardiomyopathy
por: Mordi, Ify, et al.
Publicado: (2015)

CMRI morphological and functional changes of the heart in myocarditis and dilated cardiomyopathy in acute pediatric heart failure
por: Kharabish, Ahmed E
Publicado: (2016)

Epicardial adipose tissue evaluated with cardiac magnetic resonance in normal subject and in patients with ischemic and dilated cardiomyopathies
por: Secchi, Francesco, et al.
Publicado: (2016)

Prognostic value of late enhancement in cardiac magnetic resonance in patients with dilated cardiomyopathy: a meta-analysis
por: Secchi, Francesco, et al.
Publicado: (2016)

Diffuse myocardial fibrosis in early forms of dilated cardiomyopathy: insights from T1 mapping cardiovascular magnetic resonance
por: aus dem Siepen, Fabian, et al.
Publicado: (2013)

Cardiac Magnetic Resonance for evaluating early outcomes of stem cell therapy in non-ischemic dilated cardiomyopathy
por: Gulati, Gurpreet S, et al.
Publicado: (2011)

Bio-imaging: late gadolinium enhancement in dilated cardiomyopathy and its relation to novel biomarkers of fibrosis and remodeling
por: Abdel-Aty, Hassan, et al.
Publicado: (2013)

Clinical and echocardiographic differences in patients with dilated cardiomyopathy in the frame depending preserved left ventricular contractile reserve
por: Peric, V, et al.
Publicado: (2013)

Feature tracking cardiac magnetic resonance imaging for the evaluation of myocardial strain in patients with dilated cardiomyopathy and in healthy controls
por: Breuninger, Kristin, et al.
Publicado: (2013)

Differences in virus prevalence and load in the hearts of patients with chronic dilated cardiomyopathy with and without immune-mediated inflammatory disease
por: Dennert, R, et al.
Publicado: (2010)

Predicting mortality in patients with non-ischemic dilative cardiomyopathy: Potential of extracellular volume imaging by cardiovascular magnetic resonance
por: Koopmann, Katharina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cu7gipi5vi6s7lfn1dqc6nm7eh